[Harmlessness of resumption of PAS therapy after a hemolytic accident; pathogenic considerations].
D000059:Accidents; D010131:Aminosalicylic Acid / Q000009:adverse effects*; D000740:Anemia; D000743:Anemia, Hemolytic / Q000209:etiology*; D002648:Child; D006801:Humans; D007223:Infant; D014376:Tuberculosis; D014390:Tuberculosis, Meningeal
D010131:Aminosalicylic Acid
ANEMIA, HEMOLYTIC/etiology and pathogenesis; PARA-AMINOSALICYLIC ACID/injurious effects; TUBERCULOSIS, MENINGEAL/in infant and child
Innocuité de la reprise de la thérapeutique après un accident hémolytique au P.A.S; considérations pathogéniques.